Funyuns and flu shots? Gas station company ventures into urgent care

FHS
August 16, 2023
11:48 am

When Lou Ellen Horwitz first learned that a gas station company was going to open a chain of urgent care clinics, she was skeptical.

Kentucky’s Promising Opioid Addiction Treatment Initiative Stalls As New AG Ousts Leading Advocate

Once a promising pioneer state in ibogaine research for the treatment of opioid use disorder, Kentucky’s appointment of Attorney General Russell Coleman has brought about the removal

January 2, 2024

Walgreens Sells $1.85B of AmerisourceBergen Shares, Reduces Stake by 16%

by Jasmine Pennic 08/04/2023 Leave a Comment What You Should Know: Walgreens Boots Alliance announces the sale of shares of AmerisourceBergen Corporation valued at $1.85B

August 4, 2023

FILAMENT HEALTH ANNOUNCES HEALTH CANADA AUTHORIZATION FOR PHASE 2 CLINICAL TRIAL STUDYING BOTANICAL PSILOCYBIN FOR OPIOID USE DISORDER | Psychedelic Invest

Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE:7QS) (“Filament” or the “Company“), a clinical‐stage natural psychedelic drug development company, today announced Health Canada approval for a phase 2 clinical

October 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.